Utilization of Cardiovascular Magnetic Resonance Imaging for Resumption of Athletic Activities Following COVID-19 Infection: An Expert Consensus Document on Behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention Leadership and Endorsed by the Society for Cardiovascular Magnetic Resonance

The global pandemic of COVID-19 caused by infection with SARS-CoV-2 is now entering its fourth year with little evidence of abatement. As of December 2022, the World Health Organization Coronavirus (COVID-19) Dashboard reported 643 million cumulative confirmed cases of COVID-19 worldwide and 98 mill...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruberg, Frederick L., Baggish, Aaron L., Hays, Allison G., Jerosch-Herold, Michael, Kim, Jiwon, Ordovas, Karen G., Reddy, Gautham, Shenoy, Chetan, Weinsaft, Jonathan W., Woodard, Pamela K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848221/
https://www.ncbi.nlm.nih.gov/pubmed/36541203
http://dx.doi.org/10.1161/CIRCIMAGING.122.014106
_version_ 1784871658424631296
author Ruberg, Frederick L.
Baggish, Aaron L.
Hays, Allison G.
Jerosch-Herold, Michael
Kim, Jiwon
Ordovas, Karen G.
Reddy, Gautham
Shenoy, Chetan
Weinsaft, Jonathan W.
Woodard, Pamela K.
author_facet Ruberg, Frederick L.
Baggish, Aaron L.
Hays, Allison G.
Jerosch-Herold, Michael
Kim, Jiwon
Ordovas, Karen G.
Reddy, Gautham
Shenoy, Chetan
Weinsaft, Jonathan W.
Woodard, Pamela K.
author_sort Ruberg, Frederick L.
collection PubMed
description The global pandemic of COVID-19 caused by infection with SARS-CoV-2 is now entering its fourth year with little evidence of abatement. As of December 2022, the World Health Organization Coronavirus (COVID-19) Dashboard reported 643 million cumulative confirmed cases of COVID-19 worldwide and 98 million in the United States alone as the country with the highest number of cases. Although pneumonia with lung injury has been the manifestation of COVID-19 principally responsible for morbidity and mortality, myocardial inflammation and systolic dysfunction though uncommon are well-recognized features that also associate with adverse prognosis. Given the broad swath of the population infected with COVID-19, the large number of affected professional, collegiate, and amateur athletes raises concern regarding the safe resumption of athletic activity (return to play) following resolution of infection. A variety of different testing combinations that leverage ECG, echocardiography, circulating cardiac biomarkers, and cardiovascular magnetic resonance imaging have been proposed and implemented to mitigate risk. Cardiovascular magnetic resonance in particular affords high sensitivity for myocarditis but has been employed and interpreted nonuniformly in the context of COVID-19 thereby raising uncertainty as to the generalizability and clinical relevance of findings with respect to return to play. This consensus document synthesizes available evidence to contextualize the appropriate utilization of cardiovascular magnetic resonance in the return to play assessment of athletes with prior COVID-19 infection to facilitate informed, evidence-based decisions, while identifying knowledge gaps that merit further investigation.
format Online
Article
Text
id pubmed-9848221
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-98482212023-01-19 Utilization of Cardiovascular Magnetic Resonance Imaging for Resumption of Athletic Activities Following COVID-19 Infection: An Expert Consensus Document on Behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention Leadership and Endorsed by the Society for Cardiovascular Magnetic Resonance Ruberg, Frederick L. Baggish, Aaron L. Hays, Allison G. Jerosch-Herold, Michael Kim, Jiwon Ordovas, Karen G. Reddy, Gautham Shenoy, Chetan Weinsaft, Jonathan W. Woodard, Pamela K. Circ Cardiovasc Imaging Special Report The global pandemic of COVID-19 caused by infection with SARS-CoV-2 is now entering its fourth year with little evidence of abatement. As of December 2022, the World Health Organization Coronavirus (COVID-19) Dashboard reported 643 million cumulative confirmed cases of COVID-19 worldwide and 98 million in the United States alone as the country with the highest number of cases. Although pneumonia with lung injury has been the manifestation of COVID-19 principally responsible for morbidity and mortality, myocardial inflammation and systolic dysfunction though uncommon are well-recognized features that also associate with adverse prognosis. Given the broad swath of the population infected with COVID-19, the large number of affected professional, collegiate, and amateur athletes raises concern regarding the safe resumption of athletic activity (return to play) following resolution of infection. A variety of different testing combinations that leverage ECG, echocardiography, circulating cardiac biomarkers, and cardiovascular magnetic resonance imaging have been proposed and implemented to mitigate risk. Cardiovascular magnetic resonance in particular affords high sensitivity for myocarditis but has been employed and interpreted nonuniformly in the context of COVID-19 thereby raising uncertainty as to the generalizability and clinical relevance of findings with respect to return to play. This consensus document synthesizes available evidence to contextualize the appropriate utilization of cardiovascular magnetic resonance in the return to play assessment of athletes with prior COVID-19 infection to facilitate informed, evidence-based decisions, while identifying knowledge gaps that merit further investigation. Lippincott Williams & Wilkins 2022-12-21 2023-01 /pmc/articles/PMC9848221/ /pubmed/36541203 http://dx.doi.org/10.1161/CIRCIMAGING.122.014106 Text en © 2022 The Authors. https://creativecommons.org/licenses/by/4.0/Circulation: Cardiovascular Imaging is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Special Report
Ruberg, Frederick L.
Baggish, Aaron L.
Hays, Allison G.
Jerosch-Herold, Michael
Kim, Jiwon
Ordovas, Karen G.
Reddy, Gautham
Shenoy, Chetan
Weinsaft, Jonathan W.
Woodard, Pamela K.
Utilization of Cardiovascular Magnetic Resonance Imaging for Resumption of Athletic Activities Following COVID-19 Infection: An Expert Consensus Document on Behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention Leadership and Endorsed by the Society for Cardiovascular Magnetic Resonance
title Utilization of Cardiovascular Magnetic Resonance Imaging for Resumption of Athletic Activities Following COVID-19 Infection: An Expert Consensus Document on Behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention Leadership and Endorsed by the Society for Cardiovascular Magnetic Resonance
title_full Utilization of Cardiovascular Magnetic Resonance Imaging for Resumption of Athletic Activities Following COVID-19 Infection: An Expert Consensus Document on Behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention Leadership and Endorsed by the Society for Cardiovascular Magnetic Resonance
title_fullStr Utilization of Cardiovascular Magnetic Resonance Imaging for Resumption of Athletic Activities Following COVID-19 Infection: An Expert Consensus Document on Behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention Leadership and Endorsed by the Society for Cardiovascular Magnetic Resonance
title_full_unstemmed Utilization of Cardiovascular Magnetic Resonance Imaging for Resumption of Athletic Activities Following COVID-19 Infection: An Expert Consensus Document on Behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention Leadership and Endorsed by the Society for Cardiovascular Magnetic Resonance
title_short Utilization of Cardiovascular Magnetic Resonance Imaging for Resumption of Athletic Activities Following COVID-19 Infection: An Expert Consensus Document on Behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention Leadership and Endorsed by the Society for Cardiovascular Magnetic Resonance
title_sort utilization of cardiovascular magnetic resonance imaging for resumption of athletic activities following covid-19 infection: an expert consensus document on behalf of the american heart association council on cardiovascular radiology and intervention leadership and endorsed by the society for cardiovascular magnetic resonance
topic Special Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848221/
https://www.ncbi.nlm.nih.gov/pubmed/36541203
http://dx.doi.org/10.1161/CIRCIMAGING.122.014106
work_keys_str_mv AT rubergfrederickl utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc
AT baggishaaronl utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc
AT haysallisong utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc
AT jeroschheroldmichael utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc
AT kimjiwon utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc
AT ordovaskareng utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc
AT reddygautham utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc
AT shenoychetan utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc
AT weinsaftjonathanw utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc
AT woodardpamelak utilizationofcardiovascularmagneticresonanceimagingforresumptionofathleticactivitiesfollowingcovid19infectionanexpertconsensusdocumentonbehalfoftheamericanheartassociationcounciloncardiovascularradiologyandinterventionleadershipandendorsedbythesocietyforc